Maxillary mucormycosis and aspergillosis in post-COVID-19 patients in Mexico : A case series
Copyright © 2023 Elsevier Masson SAS. All rights reserved..
BACKGROUND: Fungal infections, during or as a consequence of SARS-CoV-2 infection, associated with uncontrolled diabetes mellitus and indiscriminate use of corticosteroids have been reported. In the jaw, mostly mucormycosis has been diagnosed in hospitals.
METHODS: A retrospective, cross-sectional, descriptive study of the clinical, imaging, and histopathologic characteristics of maxillary invasive fungal infection in post-COVID-19 patients diagnosed in a private non-hospital oral pathology service in Mexico during 2020-2022 was conducted.
RESULTS: We found 20 cases of maxillary invasive fungal infections in post-COVID-19 patients, 75% including a diagnosis of mucormycosis and 25% diagnosed as probable aspergillosis. The most common signs and symptoms were exposed necrotic bone followed by tooth mobility, discharge, and pain. On imaging, unilateral maxillary sinus involvement was observed in 6 cases (30%), and bilateral maxillary sinus involvement was observed in 3 cases (15%).
CONCLUSIONS: It is essential to consider the association of osteonecrosis of the jaw in post-COVID-19 patients, with aspergillosis, not only mucormycosis, for early diagnosis and appropriate treatment.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:125 |
|---|---|
| Enthalten in: |
Journal of stomatology, oral and maxillofacial surgery - 125(2024), 1 vom: 08. Feb., Seite 101615 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Urias-Barreras, Cynthia M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Aspergillosis |
|---|
| Anmerkungen: |
Date Completed 05.02.2024 Date Revised 04.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jormas.2023.101615 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361460724 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361460724 | ||
| 003 | DE-627 | ||
| 005 | 20240404234253.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jormas.2023.101615 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1364.xml |
| 035 | |a (DE-627)NLM361460724 | ||
| 035 | |a (NLM)37648209 | ||
| 035 | |a (PII)S2468-7855(23)00236-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Urias-Barreras, Cynthia M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Maxillary mucormycosis and aspergillosis in post-COVID-19 patients in Mexico |b A case series |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.02.2024 | ||
| 500 | |a Date Revised 04.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a BACKGROUND: Fungal infections, during or as a consequence of SARS-CoV-2 infection, associated with uncontrolled diabetes mellitus and indiscriminate use of corticosteroids have been reported. In the jaw, mostly mucormycosis has been diagnosed in hospitals | ||
| 520 | |a METHODS: A retrospective, cross-sectional, descriptive study of the clinical, imaging, and histopathologic characteristics of maxillary invasive fungal infection in post-COVID-19 patients diagnosed in a private non-hospital oral pathology service in Mexico during 2020-2022 was conducted | ||
| 520 | |a RESULTS: We found 20 cases of maxillary invasive fungal infections in post-COVID-19 patients, 75% including a diagnosis of mucormycosis and 25% diagnosed as probable aspergillosis. The most common signs and symptoms were exposed necrotic bone followed by tooth mobility, discharge, and pain. On imaging, unilateral maxillary sinus involvement was observed in 6 cases (30%), and bilateral maxillary sinus involvement was observed in 3 cases (15%) | ||
| 520 | |a CONCLUSIONS: It is essential to consider the association of osteonecrosis of the jaw in post-COVID-19 patients, with aspergillosis, not only mucormycosis, for early diagnosis and appropriate treatment | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Aspergillosis | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Invasive fungal infections | |
| 650 | 4 | |a Mucormycosis | |
| 650 | 4 | |a Oral manifestations | |
| 700 | 1 | |a Rodríguez-Archilla, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Canizalez-Roman, Adrian |e verfasserin |4 aut | |
| 700 | 1 | |a Bastidas, Daniela A |e verfasserin |4 aut | |
| 700 | 1 | |a León-Sicairos, Nidia M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of stomatology, oral and maxillofacial surgery |d 2017 |g 125(2024), 1 vom: 08. Feb., Seite 101615 |w (DE-627)NLM270196927 |x 2468-7855 |7 nnns |
| 773 | 1 | 8 | |g volume:125 |g year:2024 |g number:1 |g day:08 |g month:02 |g pages:101615 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jormas.2023.101615 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 125 |j 2024 |e 1 |b 08 |c 02 |h 101615 | ||